Healthcare Realty Trust’s (HR) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated their buy rating on shares of Healthcare Realty Trust (NYSE:HR) in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a $20.00 target price on the real estate investment trust’s stock.

Other equities research analysts have also issued research reports about the stock. JPMorgan Chase & Co. dropped their price objective on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a “neutral” rating for the company in a report on Thursday, June 26th. Scotiabank raised shares of Healthcare Realty Trust from a “sector perform” rating to a “sector outperform” rating and upped their price objective for the company from $18.00 to $20.00 in a report on Friday, September 5th. Wells Fargo & Company upped their price objective on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the company an “underweight” rating in a report on Wednesday, August 27th. Finally, Wall Street Zen lowered shares of Healthcare Realty Trust from a “hold” rating to a “sell” rating in a report on Saturday, May 31st. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $17.67.

Healthcare Realty Trust Stock Performance

NYSE:HR opened at $18.37 on Wednesday. The company has a fifty day moving average of $16.64 and a two-hundred day moving average of $15.98. The stock has a market capitalization of $6.46 billion, a PE ratio of -15.97 and a beta of 0.94. Healthcare Realty Trust has a fifty-two week low of $14.09 and a fifty-two week high of $18.90.

Healthcare Realty Trust (NYSE:HR) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. The business had revenue of $287.07 million during the quarter, compared to analyst estimates of $290.83 million. During the same quarter in the prior year, the firm earned $0.38 earnings per share. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. Research analysts forecast that Healthcare Realty Trust will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Thursday, August 14th were paid a $0.24 dividend. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.96 annualized dividend and a dividend yield of 5.2%. Healthcare Realty Trust’s dividend payout ratio (DPR) is presently -83.48%.

Insider Activity at Healthcare Realty Trust

In other news, Director Thomas N. Bohjalian bought 10,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average price of $16.46 per share, with a total value of $164,600.00. Following the completion of the acquisition, the director directly owned 75,520 shares in the company, valued at $1,243,059.20. The trade was a 15.26% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Julie F. Wilson sold 15,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $18.00, for a total transaction of $270,000.00. Following the sale, the executive vice president directly owned 113,419 shares in the company, valued at approximately $2,041,542. The trade was a 11.68% decrease in their position. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

Institutional Investors Weigh In On Healthcare Realty Trust

Several institutional investors have recently made changes to their positions in the stock. Harbor Capital Advisors Inc. boosted its position in shares of Healthcare Realty Trust by 16.4% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,945 shares of the real estate investment trust’s stock worth $84,000 after purchasing an additional 695 shares in the last quarter. Peak Financial Advisors LLC boosted its position in shares of Healthcare Realty Trust by 6.8% during the 1st quarter. Peak Financial Advisors LLC now owns 11,413 shares of the real estate investment trust’s stock worth $193,000 after purchasing an additional 728 shares in the last quarter. ProShare Advisors LLC boosted its position in shares of Healthcare Realty Trust by 4.8% during the 4th quarter. ProShare Advisors LLC now owns 16,581 shares of the real estate investment trust’s stock worth $281,000 after purchasing an additional 756 shares in the last quarter. Focus Financial Network Inc. boosted its position in shares of Healthcare Realty Trust by 6.9% during the 1st quarter. Focus Financial Network Inc. now owns 11,868 shares of the real estate investment trust’s stock worth $201,000 after purchasing an additional 762 shares in the last quarter. Finally, Comprehensive Money Management Services LLC boosted its position in shares of Healthcare Realty Trust by 4.7% during the 1st quarter. Comprehensive Money Management Services LLC now owns 17,918 shares of the real estate investment trust’s stock worth $303,000 after purchasing an additional 800 shares in the last quarter.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.